Research workbench
Crystal structure of the R395G mutant form of coronafacic acid ligase from pectobacterium brasiliense
Analyse Crystal structure of the R395G mutant form of coronafacic acid ligase from… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 7A9J
- Type
- protein
- Length
- 503 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Cfl
- UniProt
- M4GWN4
- Ligands
- R4Z, PO4
- Pockets
- 3 · best druggability 0.62
Structure
x-ray diffraction · 1 distinct chain · 35% helix, 27% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Cfl | protein | 503 | 35% helix, 27% strand | M4GWN4 |
Ligands and binding sites
- R4Z · 6-ethyl-1-oxidanylidene-indene-4-carboxylic acid · ligand · chains A
- PO4 · Phosphate ion · ion · 2 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 388 | 0.62 | 0.77 | 45 | empty |
| 2 | 405 | 0.61 | 0.76 | 58 | R4Z, PO4 |
| 3 | 116 | 0.41 | 0.76 | 22 | empty |
Compared structures
- 7A9J · Crystal structure of the R395G mutant form of Coronafacic Acid Ligase from Pectobacterium… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt M4GWN4
- Elsewhere: RCSB PDB 7A9J · PDBe 7A9J · UniProt M4GWN4
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.